Climb Biotherapeutics, Inc. (CLYM) - Analysis

1.29000 USD

0.09

7.50%

Last update May 16, 3:59 PM EDT

Pre-market

Day range

1.29000

1.20000

1.32500

Previous close

1.20000

Open

1.20000

Access this stock data via API

Climb Biotherapeutics, Inc.

1.29

0.09

7.50%

Analysis

Revenue estimate	Current quarter(Jun 2025)	Next quarter(Sep 2025)	Current year(Dec 2025)	Next year(Dec 2026)
Number of Analysts	1	1	1	1
Avg. estimate	0	0	0	0
Low estimate	0	0	0	0
High estimate	0	0	0	0
Last year sales	—	—	0	0
Sales growth	—	—	0	0

EPS trend	Current quarter(Jun 2025)	Next quarter(Sep 2025)	Current year(Dec 2025)	Next year(Dec 2026)
Current estimate	0	0	0	0
7 days ago	0	0	0	0
30 days ago	0	0	0	0
60 days ago	0	0	0	0
90 days ago	0	0	0	0

EPS revisions	Current quarter(Jun 2025)	Next quarter(Sep 2025)	Current year(Dec 2025)	Next year(Dec 2026)
Up last 7 days	0	0	0	0
Up last 30 days	0	0	0	0
Down last 7 days	0	0	0	0
Down last 30 days	0	0	0	0